Status:
COMPLETED
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Advanced Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
This study is a non-interventional retrospective observational study performed on secondary data from a German multi-site cohort registry, the German national registry of skin cancer (ADOReg).
Eligibility Criteria
Inclusion
- Signed informed consent for inclusion in ADOReg registry must be documented at study site
- Diagnosis of advanced (nonresectable or metastatic) melanoma in stage III or stage IV
- Participants received any systemic therapy to treat the advanced melanoma
- First-line systemic treatment was initiated within the index window (19-Jun-2015 to 30-Jun-2018)
Exclusion
- Age \<18 years at index date
- Receipt of clinical trial study drug at any time
Key Trial Info
Start Date :
January 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 7 2020
Estimated Enrollment :
1008 Patients enrolled
Trial Details
Trial ID
NCT05426239
Start Date
January 9 2019
End Date
September 7 2020
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site0001
Frankfurt, Germany, 60549